LANNETT CO INC
DelistedCIK 57725fmd_18M9X76H8DYAEN8JMFNSR89KYQManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jul 01, 2009 to Mar 31, 2023, 56 periods
| Line item | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 151 | 274 | 407 | 542 | 633 | 685 | 655 | 546 | 479 | 341 |
| Cost of revenue | 94 | 99 | 100 | – | – | – | – | – | – | – |
| Gross profit | 57 | 154 | 306 | 286 | 301 | 289 | 244 | 165 | 76 | 33 |
| Research and development | 16 | 28 | 30 | 45 | 42 | 29 | 39 | 30 | 24 | 22 |
| Selling, general and administrative | 22 | 39 | 45 | 68 | 73 | 82 | 88 | 79 | 68 | 81 |
| Total operating expenses | 39 | 66 | 80 | 156 | 215 | 159 | 506 | 146 | 313 | 209 |
| Operating income | 19 | 88 | 226 | 131 | 86 | 130 | (262) | 20 | (237) | (176) |
| Interest expense | 0 | 0 | 0 | 66 | 89 | 86 | 85 | 67 | 54 | 58 |
| Interest and investment income | 0 | 0 | 0 | – | – | – | – | – | – | – |
| Other non-operating income (expense) | 2 | 2 | 1 | (69) | (86) | (79) | (84) | (68) | (66) | (58) |
| Income before taxes | 21 | 90 | 227 | 62 | 1 | 51 | (346) | (49) | (303) | (234) |
| Income tax expense | 7 | 33 | 77 | 17 | 1 | 22 | (74) | (15) | 61 | (2) |
| Net income from continuing operations | 13 | 57 | 150 | 45 | (1) | 29 | (272) | (33) | (363) | (232) |
| Net income | 13 | 57 | 150 | 45 | (1) | 29 | (272) | (33) | (363) | (232) |
| Net income to common shareholders | 13 | 57 | 150 | 45 | (1) | 29 | (272) | (33) | (363) | (232) |